期刊文献+

甲泼尼龙联合艾拉莫德治疗老年原发性干燥综合征患者的临床效果 被引量:5

Clinical effects of Methylprednisolone combined with Iguratimod in treatment of senile primary Sjogren’s syndrome
下载PDF
导出
摘要 目的:观察甲泼尼龙联合艾拉莫德治疗老年原发性干燥综合征患者的临床效果。方法:选取80例老年原发性干燥综合征患者为研究对象,采用随机数字表法分成研究组和对照组,每组40例。对照组予甲泼尼龙联合硫酸羟氯喹治疗,研究组予甲泼尼龙联合艾拉莫德治疗,比较两组临床疗效,治疗前后类风湿因子(RF)、免疫球蛋白G(IgG)、抗心磷脂抗体(ACL)水平,以及不良反应发生率。结果:研究组治疗总有效率为92.50%,高于对照组的75.00%,差异有统计学意义(P<0.05);治疗后,两组RF、IgG及ACL水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);研究组不良反应发生率为5.00%,低于对照组的20.00%,差异有统计学意义(P<0.05)。结论:甲泼尼龙联合艾拉莫德治疗老年原发性干燥综合征患者效果较好,可改善免疫功能,并可降低不良反应发生率。 Objective:To explore clinical effects of Methylprednisolone combined with Iguratimod in treatment of senile primary Sjogren’s syndrome.Methods:80 senile patients with primary Sjogren’s syndrome were selected as the research objects,and divided into study group and control group by using the random number table method,40 cases in each group.The control group was treated with Methylprednisolone combined with Hydroxychloroquine sulfate,while the study group was treated with Methylprednisolone combined with Iguratimod.The clinical efficacy,the levels of rheumatoid factor(RF),immunoglobulin G(IgG),and anticardiolipin antibody(ACL)before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 92.50%,which was higher than 75.00%in the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of RF,IgG and ACL in the two groups were lower than those before the treatment;those of the study group were significantly lower than those of the control group;and the differences were statistically significant(P<0.05).Further,the incidence of adverse reactions in the study group was 5.00%,which was lower than 20.00%in the control group,and the difference was statistically significant(P<0.05).Conclusions:Methylprednisolone combined with Iguratimod is effective in the treatment of the senile patients with primary Sjogren’s syndrome.Moreover,it can improve the immune function and reduce the incidence of adverse reactions.
作者 顾静 GU Jing(Department of Rheumatology and Immunology of Yingkou Central Hospital,Yingkou 115004 Liaoning,China)
出处 《中国民康医学》 2020年第18期1-2,5,共3页 Medical Journal of Chinese People’s Health
关键词 艾拉莫德 硫酸羟氯喹 甲泼尼龙 老年原发性干燥综合征 Iguratimod Hydroxychloroquine sulfate Methylprednisolone Senile primary Sjogren’s syndrome
  • 相关文献

参考文献6

二级参考文献51

  • 1蒋叶,余书勤.核转录因子-κB信号通路在内毒素致急性肺损伤中的作用[J].中国急救医学,2004,24(12):902-904. 被引量:14
  • 2蒋叶,吕伟,余书勤,姚琳,绪广林,张锡然.艾拉莫德对脂多糖激活大鼠肺泡巨噬细胞系TNFα产生及NF-κB活性的抑制作用[J].药学学报,2006,41(5):401-405. 被引量:17
  • 3董怡,赵岩,郭晓萍,李小春,唐福林,高岩,赵家良.原发性干燥综合征诊断标准的初步研究[J].中华内科杂志,1996,35(2):114-117. 被引量:68
  • 4蔡丽敏,陈志强.B细胞活化因子与干燥综合征[J].国际皮肤性病学杂志,2007,33(2):95-97. 被引量:6
  • 5Vitali C, Bombardieri S, Jonsson R, et al. Classication criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis,2002,61:554-558.
  • 6Fox RI, Robinson C, Curd JC, et al. Sjogren's syndrome: proposed criteria for classification. Arthritis Rheum, 1986,29: 577-585.
  • 7Vitali C, Bornbardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjogren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum, 1993,36: 340-347.
  • 8Manthorpe M. Sjogren' s syndrome criteria. Ann Rheum Dis, 2002,, 61:482-484.
  • 9Vitali C Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classication criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study.Ann Rheum Dis, 1996,55:116-121.
  • 10Fries JF, Hochberg MC, Medsger TA, et al. Criteria for rheumatic diseases: different types and functions. Arthritis Rheum, 1994, 37 :454-462.

共引文献188

同被引文献81

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部